Built for Life Sciences, Driven by Strategy.
At Putnam, AI has become foundational to our approach. Our experts are strategically and safely unlocking the tremendous value of AI through tools and solutions like InizioNavigator.ai, to support our clients in identifying use cases to solve their complex challenges.
With our people at the center of innovation, we combine deep scientific expertise, strategic insight, and advanced analytics to help clients become AI-ready and deploy solutions that drive smarter, faster decisions and measurable impact.
We equip teams with processes and platforms to adopt and activate AI at scale, whether it’s support with analyzing insights or building custom solutions, we ensure your team is AI-ready.
We use custom models and GenAI solutions that are compliant and built specifically for Life Sciences to help clients across insight generation, targeting, and forecasting.
Expert human guidance coupled with intuitive tools and solutions, allows us translate complex data into actionable insights to move with speed, enabling cross-functional alignment and confident decisions across the product lifecycle.
Our end-to-end data solution that establishes a unified dataset by integrating diverse sources of patient-level and provider-level data, addressing data gaps, and providing a comprehensive view of the competitive landscape.
A tool part of the InizioNavigator.ai platform, using GenAI to allow our Medical Affairs experts bring clients actionable insights faster and identify impact metrics aligned to strategic imperatives.
Expert guidance coupled with intuitive tools and solutions, allows us translate complex data into actionable insights to move with speed, enabling cross-functional alignment and confident decisions across the product lifecycle.
A data platform that combines human expertise and AI-driven insights, so our consultants can support you with faster strategic decision making when bringing your drugs to market.
See how we’re bringing together the intelligence of our people and the intelligence behind AI to help clients make strategic, confident decisions and develop innovative solutions that maximize patient outcomes.
Read how our client aims to locate organizations advancing AI algorithms for rare disease detection.
Assessing the opportunity and investment of AI and biomarker diagnostic solutions.
Putnam established technical feasibility for use of Gen AI to create Plain Language Summaries (PLS).
Used GenAI to benchmark digital voice in oncology, boosting engagement & leadership via LinkedIn, DEI & clinical messaging.
Get the latest insights and perspectives from our experts.
AI is transforming Medical Affairs, unlocking real-time insights from claims & EHR data to improve evidence generation, market shaping & patient care.
We explore two instances where our consulting teams used AssetNav to help clients prioritize promising BD&L opportunities in oncology.
ClarityNav reveals rising momentum for Lp(a) at ACC 2025, merging scientific data with digital insights to guide strategy.
GLP-1s are redefining cardiometabolic care. Explore key insights, trials, and whitespace from ACC 2025 with ClarityNav analysis.
With our people at the center of innovation, we combine deep scientific expertise, strategic insight, and advanced analytics to help clients become AI-ready and deploy solutions that drive smarter, faster decisions and measurable impact.
